Keryx Biopharmaceuticals Inc

More Info

General Info

Alexion Pharmaceuticals is engaged in the discovery and development of therapeutic products aimed at treating patients with an array of diseases, including hematologic and cardiovascular disorders, autoimmune diseases and cancer. Alexion's two primary product candidates, pexelizumab and eculizumab, are currently undergoing evaluation in several clinical development programs with the Federal Drug Administration. Alexion is engaged in discovering and developing a pipeline of additional antibody therapeutics targeting severe unmet medical needs, through its wholly owned subsidiary, Alexion Antibody Technologies. During the fiscal year ended July 31, 2005, eculizumab was in Phase III clinical development for treatment of paroxysmal nocturnal hemoglobinuria , a chronic hematologic disease, and pexelizumab was in clinical development for two acute cardiac indications. Alexion is also pursuing additional potential indications for eculizumab and has other product candidates in earlier stages of development. Alexion Pharmaceuticals is based in Cheshire, Conn.

Email

Email Business

BBB Rating

A+

BBB Rating and Accreditation information may be delayed up to a week.

Extra Phones

Phone: (475) 230-2596

Fax: (203) 271-8198

Neighborhoods

Seaport District, D Street - West Broadway, South Boston

AKA

Alexion Pharmaceuticals, Inc.

Aoi Pharmaceuticals Inc

Other Links

http://www.alexion.com

http://keryx.com

Category

Pharmaceutical Products-Wholesale & Manufacturers

Reviews

Details

Phone: (617) 466-3500

Address: 121 Seaport Blvd, Boston, MA 02210

Website: http://www.alexion.com